With the IBB biotechnology ETF poised to have its best quarter in six years and analysts seeing further upside for the space, biotech appears to be a healthy trade – literally and figuratively. These two biotech stocks in particular could be among the best bets for a breakout. CLICK HERE.
A Healthy Trade (In More Ways Than One)
- by Ashley Hayes
Tags:Biotech StocksETFHealthy TradesIBB Biotechnology InvestmentsInvestmentInvestorMarket AnalystsStock MarketStocks